Description:
Home Page: www.bio-techne.com
614 McKinley Place N.E.
Minneapolis,
MN
55413
United States
Phone:
612 379 8854
Officers
| Name | Title |
|---|---|
| Mr. Charles R. Kummeth | CEO, Pres & Director |
| Mr. James T. Hippel | Exec. VP of Fin. & CFO |
| Ms. Brenda S. Furlow J.D. | Exec. VP, Gen. Counsel, Sec. & Chief Compliance Officer |
| Mr. Kim Kelderman | Pres of Diagnostics & Genomics |
| Mr. William A. Geist | Pres of Protein Sciences Segment |
| David Clair | Sr. Director of Investor Relations & Corp. Devel. |
| Mr. Gerry Andros | VP of Sales and Marketing |
| Mr. Robert M. Gavin | VP of Corp. Devel. |
| Ms. Brenda S. Everson | Sr. VP & Chief HR Officer |
| Mr. Luca Cicchetti | Managing Director |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 38.61 |
|---|---|
| Trailing PE: | 47.64 |
| Price-to-Book MRQ: | 5.8049 |
| Price-to-Sales TTM: | 49.3951 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 3200 |